JOHN PALMA: Open Payments
NPI 1730690546 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,422 in 188 payments from 17 companies in 2025. Trend: 2023 $2,774 · 2024 $3,125 · 2025 $3,422
Food & beverage: $3,422
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $609 |
| Corium, LLC | 30 | $427 |
| ABBVIE INC. | 30 | $391 |
| Vanda Pharmaceuticals Inc. | 17 | $338 |
| Otsuka America Pharmaceutical, Inc. | 15 | $308 |
| Alkermes, Inc. | 12 | $257 |
| Collegium Pharmaceutical, Inc. | 18 | $222 |
| Lundbeck LLC | 9 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $190 |
| Axsome Therapeutics, Inc. | 6 | $141 |
Products named: CAPLYTA, REXULTI, Azstarys, VRAYLAR, FANAPT, ARISTADA, Jornay PM, TRINTELLIX.
Industry payments across CT — which companies pay providers there.
